BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 6614431)

  • 1. Pharmacokinetic optimisation of aminophylline infusions in critically ill patients.
    Ilett KF; Nation RL; Silbert B; Oh TE
    Anaesth Intensive Care; 1983 Aug; 11(3):220-7. PubMed ID: 6614431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theophylline: constant-rate infusion predictions.
    Mesquita CA; Sahebjami H; Imhoff T; Thomas JP; Myre SA
    Ther Drug Monit; 1984; 6(2):157-63. PubMed ID: 6740734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraindividual changes in theophylline clearance during constant aminophylline infusion in children with acute asthma.
    Kubo M; Odajima Y; Ishizaki T; Kanagawa S; Yamaguchi M; Nagai T
    J Pediatr; 1986 Jun; 108(6):1011-5. PubMed ID: 3712142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early estimate of theophylline clearance during intravenous infusion.
    Rizzo A; Mirabella A; Ferrara G; Mangiacavallo A; Bonanno A; Bonsignore G
    Eur J Respir Dis; 1986 Apr; 68(4):291-7. PubMed ID: 3732424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid estimation of total body clearance of theophylline in patients receiving intravenous aminophylline infusion.
    Lau AH; O'Connor T; Lam G; Lui CY; Al-Bazzaz FJ; Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):12-5. PubMed ID: 3957483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a pharmacokinetic method for establishing doses of aminophylline to treat acute bronchospasm.
    Pancorbo S; Davies S; Raymond JL
    Am J Hosp Pharm; 1981 Jun; 38(6):851-6. PubMed ID: 7246557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of 11 methods for predicting theophylline dose.
    Rodvold KA; Paloucek FP; Zell M
    Clin Pharm; 1986 May; 5(5):403-8. PubMed ID: 3720210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theophylline concentrations in asthmatic patients after administration of aminophylline.
    Kordash TR; Van Dellen RG; McCall JT
    JAMA; 1977 Jul; 238(2):139-41. PubMed ID: 577283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous aminophylline dosage. Use of serum theophylline measurement for guidance.
    Weinberger MW; Matthay RA; Ginchansky EJ; Chidsey CA; Petty TL
    JAMA; 1976 May; 235(19):2110-3. PubMed ID: 946537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inconsistent absorption from a sustained-release theophylline preparation during continuous therapy in asthmatic children.
    Rogers RJ; Kalisker A; Wiener MB; Szefler SJ
    J Pediatr; 1985 Mar; 106(3):496-501. PubMed ID: 3973788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Individually-adjusted dosages of aminophylline in children with bronchial asthma].
    Paditz E; Gramatté T; Leupold W; Richter K; Feller K
    Kinderarztl Prax; 1990 Nov; 58(11):567-74. PubMed ID: 2098615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of theophylline clearance during intravenous aminophylline infusions.
    Gilman TM; Muir KT; Jung RC; Walberg CB
    J Pharm Sci; 1985 May; 74(5):508-14. PubMed ID: 4020626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetic research on theophylline].
    Tsoĭ AN; Gneushev ET; Bogovskiĭ BP; Kaz'mina EM; Abrosimov AG
    Farmakol Toksikol; 1987; 50(1):89-91. PubMed ID: 3556561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results.
    Hatton RC; Gotz VP; Robinson JD; Russell WL; Ryerson GG
    Clin Pharm; 1983; 2(4):347-52. PubMed ID: 6883961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative bioavailability of a microcrystalline theophylline tablet and uncoated aminophylline tablets.
    Sansom LN; Milne RW; Cooper D
    Eur J Clin Pharmacol; 1979; 16(6):417-21. PubMed ID: 583332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosing.
    Schulz HU; Steinijans VW; Gabel H
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):621-5. PubMed ID: 6500759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of intravenous theophylline.
    Chrzanowski FA; Niebergall PJ; Mayock RL; Taubin JM; Sugita ET
    Clin Pharmacol Ther; 1977 Aug; 22(2):188-95. PubMed ID: 884920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theophylline pharmacokinetics in Thai children.
    Vichyanond P; Aranyanark N; Visitsuntorn N; Tuchinda M
    Asian Pac J Allergy Immunol; 1994 Dec; 12(2):137-43. PubMed ID: 7612107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monitoring serum concentrations of theophylline during aminophylline infusion therapy].
    Prazáková J; Vondra V
    Cas Lek Cesk; 1985 Oct; 124(43):1332-5. PubMed ID: 4084951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.